Copyright © 2009. American Society of Health-System Pharmacists, Inc. All rights reserved. 1079-2082/04/0602-1242$06.00
Estimation of creatinine clearance in morbidly obese patientsJASMINA A. DEMIROVIC, PHARM.D., is Infectious Diseases Pharmacotherapy Resident, College of Pharmacy, University of New Mexico (UNM), Albuquerque. AMY BARTON PAI, PHARM.D., BCPS, FASN, is Associate Professor, Department of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, Albany, NY; at the time of writing she was Associate Professor of Pharmacy and Nephrology, College of Pharmacy, UNM. MANJUNATH P. PAI, PHARM.D., is Scientist, Translational Medicine, Institute for Clinical Pharmacodynamics, Ordway Research Institute, Latham, NY; at the time of writing he was Associate Professor, College of Pharmacy, UNM. Address correspondence to Dr. Manjunath P. Pai at the Institute for Clinical Pharmacodynamics, Ordway Research Institute, 43 British American Boulevard, Latham, NY 12186 (apai-icpd{at}ordwayresearch.com).
Methods. Patients age 18–75 years with a body mass index (BMI) of
Results. Fifty-four patients (mean ± S.D. age, 48.4 ± 12.9 years; TBW, 142.3 ± 41.7 kg; BMI, 50.5 ± 12.6 kg/m2) completed the study. All three equations were biased in their estimation of CLcr. Use of MDRD4 and IBW in the Cockcroft–Gault equation underestimated CLcr, while the Salazar–Corcoran equation and use of TBW or ABW in the Cockcroft–Gault equation overestimated this value. Substitution of fat-free weight or LBW in the Cockcroft–Gault equation provided unbiased estimates of CLcr.
Conclusion. An LBW estimate, based on TBW and BMI, incorporated into the Cockcroft–Gault equation provided an unbiased, relatively precise, accurate, and clinically practical estimate of 24-hour measured CLcr in morbidly obese patients.
Index terms: Calculations; Creatinine; Methodology; Obesity; Weight
|
|||||||||||||||||||||||